TP53 and Familial prostate cancer: Similar to observations in lung cancer xenografts, we have observed sustained enhancement of total and phosphorylated AMPK α subunit levels in xenografts of PC3 prostate cancer cells also, a cell line that lacks expression p53 (see Additional file 1: Figure S 1).